C7 |
C7: Complement component C7 precursor |
JAG1 |
JAG1, JAGL1: Jagged-1 precursor |
3.21 |
Evidence |
|
EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
PSMA4 |
PSMA4, PSC9: Proteasome subunit alpha type-4 |
3.21 |
Evidence |
|
EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
3.21 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
3.21 |
Evidence |
|
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
SCAP2 |
SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 |
3.205 |
Evidence |
|
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
SCAP2 |
SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 |
3.205 |
Evidence |
|
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
GRB14 |
GRB14: Growth factor receptor-bound protein 14 |
3.205 |
Evidence |
|
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
OSTF1 |
IPI00333434 |
3.205 |
Evidence |
|
GPI |
GPI: Glucose-6-phosphate isomerase |
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
3.202 |
Evidence |
|
MEF2C |
MEF2C: Myocyte-specific enhancer factor 2C |
MEF2D |
MEF2D: Myocyte-specific enhancer factor 2D |
3.202 |
Evidence |
|
RPS6KA5 |
RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 |
SEC31L1 |
IPI00305152 |
3.202 |
Evidence |
|
CDK7 |
CDK7, MO15: Cell division protein kinase 7 |
TSC1 |
TSC1, KIAA0243, TSC: Hamartin |
3.202 |
Evidence |
|
STK25 |
STK25, SOK1, YSK1: Serine/threonine-protein kinase 25 |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
3.202 |
Evidence |
|
ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
TXNRD1 |
TXNRD1: Thioredoxin reductase 1, cytoplasmic precursor |
3.202 |
Evidence |
|
CDK4 |
CDK4: Cell division protein kinase 4 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
3.202 |
Evidence |
|
HIST2H2BE |
HIST2H2BE, H2BFQ: Histone H2B type 2-E |
DOK1 |
DOK1: Docking protein 1 |
3.202 |
Evidence |
|
MBD3 |
MBD3: Methyl-CpG-binding domain protein 3 |
RBL2 |
RBL2, RB2: Retinoblastoma-like protein 2 |
3.202 |
Evidence |
|
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
CAMK1 |
CAMK1: Calcium/calmodulin-dependent protein kinase type 1 |
3.202 |
Evidence |
|
EIF4G3 |
EIF4G3: Eukaryotic translation initiation factor 4 gamma 3 |
CRSP2 |
MED14, ARC150, CRSP2, CXorf4, DRIP150, EXLM1, RGR1, TRAP170: Mediator of RNA pol |
3.202 |
Evidence |
|
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
HSF1 |
HSF1, HSTF1: Heat shock factor protein 1 |
3.202 |
Evidence |
|
H2AFX |
H2AFX, H2AX: Histone H2A.x |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
3.202 |
Evidence |
|
POLB |
POLB: DNA polymerase beta |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
3.202 |
Evidence |
|
DLG1 |
IPI00218729 |
SNTA1 |
SNTA1, SNT1: Alpha-1-syntrophin |
3.202 |
Evidence |
|
EIF3S4 |
EIF3S4: Eukaryotic translation initiation factor 3 subunit 4 |
ANKS1A |
ANKS1A, ANKS1, KIAA0229: Ankyrin repeat and SAM domain-containing protein 1A |
3.202 |
Evidence |
|
CCT4 |
CCT4, CCTD, SRB: T-complex protein 1 subunit delta |
RIN1 |
RIN1: Ras and Rab interactor 1 |
3.202 |
Evidence |
|